Post COVIDVD-PCSNCT04969237
Vitamine D in Post-COVID Patients
An observational study of Post COVID, run by Klinikum Emden at 1 site in Germany.
Trial summary
In this study routineously collected vitamine D values will compared to healthy cohorts from this year and previous years. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Post COVID
- What is being tested?
- Vitamine D in blood samples
- How many people
- 40 participants
- Where
- 1 siteGermany
- Study dates
- 1 Aug 2021to 1 Sep 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: healthy subjects and patients with post-COVID
Who may be able to join
- patients with or without post-COVID-Syndrome
Who cannot join
- substitution of vitamine D
- diseases influencing vitamine D level
Trial locations and contacts
1 site in 1 country.
About this study
In this study routineously collected vitamine D values will compared to healthy cohorts from this year and previous years.
- Conditions
- Post COVID
- Being tested
- Vitamine D in blood samples
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Vitamine D in blood samplesDiagnostic test
vitamine D values
| Study group | Role | What they receive |
|---|---|---|
| healthy subjects 2019 | subjects with diseases not influencing vitamine D values without substitution nor post-COVID Receives: Diagnostic Test: Vitamine D in blood samples | |
| healthy subjects 2020 | subjects with diseases not influencing vitamine D values without substitution nor post-COVID Receives: Diagnostic Test: Vitamine D in blood samples | |
| healthy subjects 2021 | subjects with diseases not influencing vitamine D values without substitution nor post-COVID Receives: Diagnostic Test: Vitamine D in blood samples | |
| post-COVID subjects 2021 | subjects with diseases not influencing vitamine D values without substitution with diagnosed post-COVID syndrome Receives: Diagnostic Test: Vitamine D in blood samples |
What is being measured
The primary outcome is the main question the study is designed to answer.
vitamin D values between the groups
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Jul 2021
- Study start1 Aug 2021
- Primary completion1 Sep 2021
- Study completion1 Sep 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Post COVIDStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 40 participants (actual)
Sponsor and investigators
- Lead sponsor
- Klinikum Emden
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Jens Bräunlich, Klinikum Emden
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04969237
- Sponsor's protocol ID
- 1
- Acronym
- VD-PCS
- Status last verified
- Mar 2022
- First submitted
- 16 Jul 2021
- Last updated
- 31 Mar 2022
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 31 Mar 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Vitamine D in Post-COVID Patients
- ClinicalTrials.gov ID
- NCT04969237
- Acronym / sponsor ID
- VD-PCS / 1
- Conditions
- Post COVID
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 40 participants (actual)
- Lead sponsor
- Klinikum EmdenUniversity, hospital or other
- Study start
- 1 Aug 2021 (actual)
- Primary completion
- 1 Sep 2021 (actual)
- Study completion
- 1 Sep 2021 (actual)
- First posted
- 20 Jul 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In this study routineously collected vitamine D values will compared to healthy cohorts from this year and previous years.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| healthy subjects 2019 | – | Diagnostic Test: Vitamine D in blood samplessubjects with diseases not influencing vitamine D values without substitution nor post-COVID |
| healthy subjects 2020 | – | Diagnostic Test: Vitamine D in blood samplessubjects with diseases not influencing vitamine D values without substitution nor post-COVID |
| healthy subjects 2021 | – | Diagnostic Test: Vitamine D in blood samplessubjects with diseases not influencing vitamine D values without substitution nor post-COVID |
| post-COVID subjects 2021 | – | Diagnostic Test: Vitamine D in blood samplessubjects with diseases not influencing vitamine D values without substitution with diagnosed post-COVID syndrome |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- healthy subjects and patients with post-COVID
Key inclusion criteria (1 listed)
- patients with or without post-COVID-Syndrome
Key exclusion criteria (2 listed)
- substitution of vitamine D
- diseases influencing vitamine D level
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Vitamine D in blood samplesvitamine D values | Diagnostic test | healthy subjects 2019, healthy subjects 2020, healthy subjects 2021, post-COVID subjects 2021 |
Primary outcome
vitamin D values between the groups
Time frame: 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Mar 2022.
- Individual participant dataSharing planned: Undecided
Related trials for Post COVID
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Recruiting
Home-Based Exercise Tele-Rehabilitation After COVID-19
Post SARS-CoV2 (COVID-19)
Recruiting
Whole-body Cryotherapy in Those With Chronic Fatigue: A Feasibility Study
ME/CFS, Fibromyalgia (FM)
Not yet recruitingPhase 3
The Study of Brave-LC LDN Treatment Trial
Post-acute COVID-19 Syndrome
Active, not recruitingObservational study
Epigenetic Changes in Long COVID Patients
Long COVID-19 Syndrome, Long COVID Symptoms
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Post COVID, run by Klinikum Emden at 1 site in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 31 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
vitamin D values between the groups (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Mar 2022.